Join to View Full Profile
17323 Red Oak DrHouston, TX 77090
Phone+1 281-440-5006
Dr. Pachipala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2009
Geisinger Health System (Danville)Residency, Internal Medicine, 2000 - 2003
Kurnool Medical CollegeClass of 1989
Certifications & Licensure
TX State Medical License 2007 - 2027
PA State Medical License 2000 - 2008
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification GeniusDoc EHR, GeniusDoc, Inc., 2015-2017
- CMS Meaningful Use Stage 1 Certification GeniusDoc EHR, GeniusDoc, Inc., 2015-2017
- CMS Meaningful Use Stage 1 Certification GeniusDoc, GeniusDoc, Inc., 2015-2017
Clinical Trials
- Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer. Start of enrollment: 2015 Jun 09
- Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer Start of enrollment: 2019 Jun 11
- Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Docetaxel for Metastatic Non-Small Cell Lung Cancer (NSCLC) (PRESERVE 4) Start of enrollment: 2021 Apr 30
Publications & Presentations
PubMed
- Dose Escalation Trial of the Combination of Osimertinib and Quaratusugene Ozeplasmid Gene Therapy in Patients with Advanced NSCLC.Alexander I Spira, David Berz, Robert M Jotte, Krishna K Pachipala, Mark S Berger
Clinical Lung Cancer. 2026-01-01 - 8 citationsDurvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study.Dong-Wan Kim, Byoung Chul Cho, Krishna Pachipala, Sang-We Kim, Chih-Liang Wang
Lung Cancer. 2024-04-01 - 4 citationsBilateral adrenal hemorrhage associated with essential thrombocytosis.Krishna Pachipala, David Gutknecht
American Journal of Hematology. 2006-02-01
Press Mentions
Woodlands Cancer Institute Relocates Its Medical Oncology Clinic in the Woodlands, TexasMarch 4th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
